Glow-in-the-dark cats used in vital AIDS research

By Admin
As part of Healthcare Global's look back at 2011's biggest news stories, we've revisited this one from September... Scientists in the US ha...

As part of Healthcare Global's look back at 2011's biggest news stories, we've revisited this one from September...

Scientists in the US have created green glow-in-the-dark cats as part of their research into a potential cure for HIV/AIDS.

The researchers from the Mayo Clinic have modified the DNA of domestic moggies with two different genes; a fluorescent jellyfish gene and another which can fight feline AIDS, a close relative of the human HIV/AIDS virus.

The aim of the research is to create cats that are immune to the feline immunodeficiency virus (FIV) as well as identifying ways to combat HIV/AIDS in humans.

It is also hoped the experiment will prove a natural protein can prevent cats from contriving FIV, just as it can in macaque monkeys, who naturally have a restriction factor against the virus.  

Both genes were injected into a female cat’s eggs prior to fertilisation from a male cat and the genes were passed on to their kittens.

The jellyfish gene was used to track the restrictive protein to see if it was successfully transferred, making the kittens glow green under a UV light if they are reproducing the protein in their tissues.

Eric Poeschla, a molecular biologist at the Mayo Clinic and leader of the study,said: “One of the best things about this biomedical research is that it is aimed at benefiting both human and feline health.

“It can help cats as much as people.”

Over 30 million people worldwide have died from HIV/AIDS and there is currently no effective vaccine against the virus.

Meanwhile, millions of domestic cats die from FIV every year it is also hoped the knowledge will help protect the 36 species of endangered wild felines from contracting the illness.

Our magazine is now available on the iPad. Click here to download it.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare